Babich Michael L

President and CEO at Insys Therapeutics, Inc.

Sold, on record
$29.8M
Dollars the filings state
Form 4 sales
4
Latest Mar 17, 2015
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Insys Therapeutics, Inc.Unusual
    Mar 5 2014

    Sold 288,432 shares at $74.58 ($21.5M)

    Babich Michael L, President and CEO

    Sold 98.2% of holdings ($21.9M position)5,375 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Insys Therapeutics, Inc.Plan not stated
    Oct 21 +230 days

    Sold 20,000 shares at $40.17 ($803k)

    Babich Michael L, President and CEO

    Sold 10.5% of holdings ($7.6M position)169,795 shares leftFiling

  3. 3 Form 4 sale Insys Therapeutics, Inc.Unusual
    Nov 4 +14 days

    Sold 80,000 shares at $38.66 ($3.1M)

    Babich Michael L, President and CEO

    Sold 32% of holdings ($9.7M position)169,795 shares leftFiling

  4. 4 Form 4 sale Insys Therapeutics, Inc.Unusual
    Mar 17 +133 days

    Sold 75,000 shares at $58.63 ($4.4M)

    Babich Michael L, President and CEO

    Sold 27% of holdings ($16.3M position)202,752 shares left0.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Babich Michael L
Source
Mar 17, 2015Insys Therapeutics, Inc.President and CEOForm 4 sale75,000$4.4M27.0%UnusualSEC
Nov 4, 2014Insys Therapeutics, Inc.President and CEOForm 4 sale80,000$3.1M32.0%UnusualSEC
Oct 21, 2014Insys Therapeutics, Inc.President and CEOForm 4 sale20,000$803k10.5%Plan not statedSEC
Mar 5, 2014Insys Therapeutics, Inc.President and CEOForm 4 sale288,432$21.5M98.2%UnusualSEC